Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Ikaria Steady State

Ikaria VCs looking for modest value boost in profitable biotech's IPO

November 1, 2010 7:00 AM UTC

The investors who formed Ikaria Inc. in 2007 through the combination of Ikaria Inc. and INO Therapeutics LLC aren't expecting much of a gain in valuation since the stock and cash deal valued the newco at $670 million. Last week, the company went on the road with an IPO that would value it at $710.6 million.

Ikaria updated its S-1 to sell 10 million shares at $15-$17. A $16 price would raise $160 million. The company filed in May to raise up to $200 million...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article